Therapy of pulmonary aspergillosis with newly developed azole-derivatives

H. Grysczyk, A. de Roux, H. Mauch, A. Grassot, H. Lode (Berlin, Germany)

Source: Annual Congress 2001 - Treatment of LRTI
Session: Treatment of LRTI
Session type: Thematic Poster Session
Number: 928
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Grysczyk, A. de Roux, H. Mauch, A. Grassot, H. Lode (Berlin, Germany). Therapy of pulmonary aspergillosis with newly developed azole-derivatives. Eur Respir J 2001; 16: Suppl. 31, 928

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012


Invasive pulmonary aspergillosis in immunosuppressed patients
Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections
Year: 2015



Surgery treatment of pulmonary aspergillosis
Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology
Year: 2007


Pulmonary aspergillosis – diagnostic and therapeutic challenges
Source: Eur Respir J 2005; 26: Suppl. 49, 170s
Year: 2005

PET‘s importance in chronic pulmonary aspergillosis
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006

Invasive pulmonary aspergillosis in immunocompetent patients acquired during renovation in a chest institute
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017


Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation
Source: Eur Respir J, 53 (3) 1801184; 10.1183/13993003.01184-2018
Year: 2019



Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis
Source: Eur Respir J 2012; 40: 271-273
Year: 2012


Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010


Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients
Source: Eur Respir J 2001 Jan 01;19(4):743-755
Year: 2002



Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis
Source: Eur Respir Rev 2010 19: 349-351
Year: 2010


Surgical and clinical assessment of pulmonary aspergillosis secondary to sequelar TB cavities
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Source: Eur Respir J 2011; 37: 865-872
Year: 2011



Chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016
Year: 2017



Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013